About
Neurotrack is a clinically trusted, FDA-registered cognitive health platform built to standardize and modernize cognitive screening across health systems, home health, and primary care. Founded in 2012, the company has focused on a singular mission: detect cognitive decline early to improve outcomes for patients with Alzheimer's and related dementias. The platform offers quick, friendly digital assessments that can establish a cognitive baseline in as little as 3 minutes, with additional tests available as needed. Results are instantly scored and aligned with DSM-5 standards, giving providers clear, confident insights to triage, diagnose, and refer patients efficiently. Functional questionnaires and EHR-integrated patient data enable personalized care plans tailored to each patient's level of cognitive impairment. Neurotrack supports remote and in-home administration, making it ideal for virtual care and care-at-home programs. It is HIPAA-compliant, SOC 2-certified, and compatible with any device, deploying in weeks rather than months. Over 15,000 clinicians across leading health systems use Neurotrack, and 90% of staff report it is easier to use than traditional tests like MoCA, MMSE, Mini-Cog, and SLUMS. Backed by 375+ peer-reviewed publications, funding from the NIA and Gates Foundation, and partnerships with organizations like Sutter Health, Neurotrack is built for enterprise healthcare organizations looking to close cognitive screening gaps and meet value-based care objectives.
Key Features
- Rapid Cognitive Baseline Screening: Establish a patient's cognitive baseline in as little as 3 minutes, with additional assessments available as clinical needs evolve.
- DSM-5-Aligned Instant Results: Assessments are automatically scored and aligned with DSM-5 criteria, providing clinicians with actionable, standardized insights for confident triage and referral.
- EHR Integration & Personalized Care Plans: Integrates with all major EHR systems and uses patient data to generate personalized care plans based on the severity of cognitive impairment.
- Remote & At-Home Administration: Supports virtual care and care-at-home workflows, enabling population-wide screening regardless of care setting.
- Clinician & Caregiver Support Resources: Connects patients and caregivers to local resources and ongoing support throughout the full care journey.
Use Cases
- Health systems integrating standardized cognitive screening into primary care workflows to close dementia detection gaps.
- Medicare Advantage plans and payers prioritizing annual cognitive assessments for members aged 65 and older.
- Home health and virtual care providers administering remote cognitive evaluations for homebound or rural patients.
- Clinical researchers and academic medical centers conducting population-level cognitive decline studies.
- Care coordinators using Neurotrack results to connect patients and caregivers with local dementia support resources.
Pros
- Clinically Validated & FDA-Registered: Backed by 375+ peer-reviewed publications and funding from leading institutions, giving providers and health systems high confidence in clinical accuracy.
- Fast Deployment & Easy to Use: Deploys in weeks, works on any device, and 90% of clinical staff report it is easier to use than traditional cognitive tests like MoCA and MMSE.
- Enterprise-Ready Compliance: HIPAA-compliant and SOC 2-certified with full EHR compatibility, making it suitable for large health systems and regulated care environments.
- Saves Significant Clinical Time: Providers save 10+ minutes per patient compared to traditional screening approaches, improving throughput and operational efficiency.
Cons
- Enterprise-Focused Pricing: Designed for health systems and payers rather than individual consumers; pricing and access are not publicly listed and likely require an enterprise contract.
- Limited to Cognitive Health Niche: The platform is purpose-built for cognitive screening only and does not address broader clinical assessment or patient management needs.
- Requires Clinical Context for Interpretation: While results are instantly scored, meaningful interpretation and care planning still require trained clinical staff, limiting fully autonomous deployment.
Frequently Asked Questions
What conditions does Neurotrack screen for?
Neurotrack screens for mild cognitive impairment (MCI), dementia, and Alzheimer's disease by evaluating memory, attention, and executive function through brief, standardized digital assessments.
Can Neurotrack be used for remote or at-home patient visits?
Yes. Neurotrack supports virtual care and care-at-home appointments, enabling remote administration of cognitive assessments with real-time scoring and analytics.
Does Neurotrack integrate with existing EHR systems?
Yes. Neurotrack is designed to integrate with all major EHR platforms, enabling seamless workflows and data-informed personalized care plans.
How long does a Neurotrack cognitive assessment take?
A baseline cognitive screening takes as little as 3 minutes. Additional assessments can be unlocked as needed, with most workflows saving clinicians 10 or more minutes compared to traditional tests.
Is Neurotrack HIPAA-compliant?
Yes. Neurotrack is both HIPAA-compliant and SOC 2-certified, meeting the security and privacy standards required for enterprise healthcare deployment.
